FDA Inspection 745395 — LEO Pharma Ireland

LEO Pharma Ireland — FEI 3002807468

The FDA completed an inspection of LEO Pharma Ireland on Sep 9, 2011 in Dublin 12. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 9, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dublin 12 (Ireland)